Paul Kearney
Corporate Officer/Principal at SERA PROGNOSTICS, INC.
Net worth: 1 M $ as of 2024-03-30
Profile
Paul Edward Kearney founded Integrated Diagnostics, Inc. in 2009, where he is working as Chief Scientific Officer from 2009.
Dr. Kearney also currently works at Sera Prognostics, Inc., as Chief Data Officer from 2021.
Dr. Kearney also formerly worked at Data Incites LLC, as Chief Executive Officer from 2018 to 2022, The University of Waterloo, as Assistant Professor, Institute for Systems Biology, as Senior Vice President-Special Projects, CellCarta Biosciences, Inc., as Vice President-Bioinformatics from 2001 to 2008, Integrated Diagnostics Holdings Plc, as Chief Science Officer from 2009 to 2018, and AllerGenis LLC, as Vice President-Product Development.
Dr. Kearney received his doctorate degree from the University of Toronto.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-05 | 159,038 ( 0.51% ) | 1 M $ | 2024-03-30 |
Paul Kearney active positions
| Companies | Position | Start |
|---|---|---|
| SERA PROGNOSTICS, INC. | Corporate Officer/Principal | 2021-09-30 |
Integrated Diagnostics, Inc.
 Integrated Diagnostics, Inc. Medical/Nursing ServicesHealth Services Integrated Diagnostics, Inc. operates as a molecular diagnostics firm. It develops diagnostics and measurement technologies that has a capability of measuring biomarkers for diagnosis and management of complex diseases. The company was founded by Jim Heath, David J. Galas, Leroy E. Hood, and Paul Edward Kearney and is headquartered Seattle, WA. | Founder | 2009-03-12 |
Former positions of Paul Kearney
| Companies | Position | End |
|---|---|---|
| Data Incites LLC | Chief Executive Officer | 2022-01-31 |
| INTEGRATED DIAGNOSTICS HOLDINGS PLC | Chief Tech/Sci/R&D Officer | 2018-06-30 |
CellCarta Biosciences, Inc.
 CellCarta Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services CellCarta Biosciences, Inc. develops proteomics and immune monitoring services. The firm offers integrated platforms in proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. Its services include biomarker discovery, cell engine software, cellular enumeration, clinical laboratory services, functional profiling, host cell proteins detection, phenotyping characterization and receptor occupancy. The company was founded by Martin LeBlanc in 2000 and is headquartered in Montréal, Canada. | Corporate Officer/Principal | 2007-12-31 |
AllerGenis LLC
 AllerGenis LLC Data Processing ServicesTechnology Services AllerGenis LLC specializes in detecting and managing life-threatening food allergies. AllerGenis is based in Hatfield, PA, and the CEO of the joint venture company is Jim Garner. The company develops precision, data-driven diagnostics to help healthcare providers more accurately and safely diagnose, assess, and monitor patients with food allergies. AllerGenis owns and operates a CLIA-certified laboratory and is amassing the world's largest database of phenotypic patient data derived from epitope mapping, clinical history, and patient-reported outcomes. The company was founded in 2017 through a collaboration between Genisphere and Hugh Sampson MD of the Icahn School of Medicine at Mount Sinai. | Corporate Officer/Principal | - |
Institute for Systems Biology
 Institute for Systems Biology Miscellaneous Commercial ServicesCommercial Services Institute for Systems Biology operates as a nonprofit biomedical research organization. It develops a systems approach to characterize, predict, and manipulate state transitions in biological system. The company was founded by Leroy E. Hood, Ruedi Aebersold and Alan Aderem in 2000 and is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
Training of Paul Kearney
| University of Toronto | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| SERA PROGNOSTICS, INC. | Health Services |
| INTEGRATED DIAGNOSTICS HOLDINGS PLC | Health Services |
| Private companies | 5 |
|---|---|
Integrated Diagnostics, Inc.
Integrated Diagnostics, Inc. Medical/Nursing ServicesHealth Services Integrated Diagnostics, Inc. operates as a molecular diagnostics firm. It develops diagnostics and measurement technologies that has a capability of measuring biomarkers for diagnosis and management of complex diseases. The company was founded by Jim Heath, David J. Galas, Leroy E. Hood, and Paul Edward Kearney and is headquartered Seattle, WA. | Health Services |
Institute for Systems Biology
Institute for Systems Biology Miscellaneous Commercial ServicesCommercial Services Institute for Systems Biology operates as a nonprofit biomedical research organization. It develops a systems approach to characterize, predict, and manipulate state transitions in biological system. The company was founded by Leroy E. Hood, Ruedi Aebersold and Alan Aderem in 2000 and is headquartered in Seattle, WA. | Commercial Services |
CellCarta Biosciences, Inc.
CellCarta Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services CellCarta Biosciences, Inc. develops proteomics and immune monitoring services. The firm offers integrated platforms in proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. Its services include biomarker discovery, cell engine software, cellular enumeration, clinical laboratory services, functional profiling, host cell proteins detection, phenotyping characterization and receptor occupancy. The company was founded by Martin LeBlanc in 2000 and is headquartered in Montréal, Canada. | Commercial Services |
AllerGenis LLC
AllerGenis LLC Data Processing ServicesTechnology Services AllerGenis LLC specializes in detecting and managing life-threatening food allergies. AllerGenis is based in Hatfield, PA, and the CEO of the joint venture company is Jim Garner. The company develops precision, data-driven diagnostics to help healthcare providers more accurately and safely diagnose, assess, and monitor patients with food allergies. AllerGenis owns and operates a CLIA-certified laboratory and is amassing the world's largest database of phenotypic patient data derived from epitope mapping, clinical history, and patient-reported outcomes. The company was founded in 2017 through a collaboration between Genisphere and Hugh Sampson MD of the Icahn School of Medicine at Mount Sinai. | Technology Services |
| Data Incites LLC |
- Stock Market
- Insiders
- Paul Kearney
